InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Quinn Anthony G., Chief Executive Officer. Insider active across 2 companies, notably Generation Bio Co.. Aggregated, 7 disclosures have been published. Split: 5 buys · 0 sell. Total volume traded: €609k. History available since 28 October 2021. The latest transaction was disclosed on 10 January 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Quinn Anthony G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
29,928 sharesCommon StockSEC:0001104659-26-012194:0
125,791 shares@ US$0.9650.6% of flowCommon StockSEC:0001415889-25-001417:0
Canonical exit: 10 Apr 2025 (T+90)
88,495 shares@ US$1.4149.4% of flowCommon StockSEC:0001415889-23-015857:0
Canonical exit: 29 Feb 2024 (T+90)
80,079 shares@ US$2.34445.4% of flowCommon StockSEC:0001209191-22-019929:0
Canonical exit: 14 Jun 2022 (T+90)
34,777 shares@ US$2.06417.3% of flowCommon StockSEC:0001209191-22-018942:0
Canonical exit: 9 Jun 2022 (T+90)
43,108 shares@ US$3.7037.3% of flowCommon StockSEC:0001209191-21-069350:0
Canonical exit: 9 Mar 2022 (T+90)
72,837 shares0Common StockSEC:0001415889-21-005028:0
7 of 7 declarations
About Quinn Anthony G.
Quinn Anthony G. is President and Chief Executive Officer. The declarant has 7 filings in total, and across the 7 recent filings available, the transactions are acquisitions, with EUR 608700 of buys and EUR 0 of sells between 2021-10-29 and 2026-02-09. The filings concern Aeglea BioTherapeutics, Inc. and Generation Bio Co.
